YBGJ — Yubo International Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $15.17m
- $15.29m
- $0.00m
Annual cashflow statement for Yubo International Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 February 29th | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.134 | -1.54 | -1.2 | -1.2 | -1.98 |
| Depreciation | |||||
| Non-Cash Items | — | 0.008 | — | — | 0.212 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.112 | 0.492 | 0.577 | 0.266 | 0.249 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.022 | -1.02 | -0.601 | -0.739 | -1.34 |
| Capital Expenditures | — | -0.565 | -0.04 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 0.118 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.565 | -0.04 | 0 | 0.118 |
| Financing Cash Flow Items | — | — | 0.669 | 0.746 | 1.41 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.019 | 0.127 | 0.669 | 0.746 | 1.41 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.003 | -1.36 | -0.009 | -0.012 | 0.001 |